MedPath

Development of BipolarWISE, an innovative online psychosocial interventio

Not Applicable
Recruiting
Conditions
Bipolar disorder
Carer mental health
Mental Health - Other mental health disorders
Registration Number
ACTRN12619001179123
Lead Sponsor
Barwon Health
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
22
Inclusion Criteria

All participants must:
1. Be able to speak, read, write and understand the English language

2. Have access to a mobile phone, iPad or computer

3. Have the capacity to consent to the study and comply with study procedures

Participants with bipolar disorder must:
1. Have a diagnosis of bipolar disorder using the Structured Clinical Interview for DSM-5 (SCID-5-RV).

2. Have subsyndromal levels of depression with a MADRS score between 7 and 19

3. Currently be receiving treatment for bipolar disorder from a medical practitioner

4. Nominate a current treating medical practitioner that can be contacted if the researchers become concerned about the person's welfare

Carer participants must:
1. Identify as a key informal support person, and family member, friend or partner of an adult with diagnosed bipolar disorder.

Exclusion Criteria

All participants will be excluded if they are:
1. Currently suicidal, determined by a score of 5 or greater on the MADRS Item 10

2. Currently experiencing a significant depressive episode, determined by a score of 20 or greater on the MADRS

3. Currently experiencing acute mania or hypomania, determined by a score of 12 or greater on the Young Mania Rating Scale

4. Participants who are currently psychotic, indicated by the SCID-5-RV

5. Participants with a physical or neurological disorder that will impair their ability to participate fully or give informed consent (e.g. dementia)

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
A composite outcome for participants with bipolar disorder: Acceptability of the group intervention and app, measured using brief feedback surveys designed specifically for this study. [ A composite outcome for participants with bipolar disorder: At the conclusion of all individual and group sessions (week 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13)];Participants with bipolar disorder: Helpfulness of the sessions, measured using the Helpful Aspects of Therapy Form (HAT)[ Participants with bipolar disorder: At the conclusion of all individual and group sessions (week 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13)];A composite outcome for participants with bipolar disorder: Usefulness of the group intervention and the app, measured using a one hour, semi-structured interview (feedback interview) designed specifically for this study. [ A composite outcome for participants with bipolar disorder: One week post-intervention (week 14)]
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath